Your session is about to expire
← Back to Search
HEPA Air Filtration for Cardiovascular Risk and High Blood Pressure (HAFTRAP Trial)
N/A
Recruiting
Led By Doug Brugge, PhD
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at study onset and 30 days
Awards & highlights
HAFTRAP Trial Summary
This trial is a study of whether or not a HEPA filter can reduce exposure to pollutants for people who live near highways.
Who is the study for?
This trial is for people living within 200 meters of interstate I-93 in Somerville who are home full-time and can answer questionnaires in English/Spanish. It's not for those on blood pressure or anti-inflammatory meds, with high exposure to traffic pollution elsewhere, using lots of candles/incense, having forced-air systems at home, smokers or living with smokers, or with a major heart history.Check my eligibility
What is being tested?
The study tests if HEPA air filters in homes near highways can improve heart health compared to sham (fake) filters. Participants will try both real and fake filters for 30 days each, separated by a washout period. Health effects like inflammation and blood pressure are measured to see if the filters make a difference.See study design
What are the potential side effects?
Since this trial involves using air filtration systems at home rather than taking medication, there aren't typical drug side effects involved. However, participants might experience placebo effects during the sham filtration phase.
HAFTRAP Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at study onset and 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at study onset and 30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in High Sensitivity C-Reactive Protein (hsCRP) at 1 Month
Change in Systolic Blood Pressure at 1 Month
Secondary outcome measures
Change in D-dimer at 1 Month
HAFTRAP Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: HEPA FiltrationActive Control1 Intervention
Group II: Sham HEPA FiltrationPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Tufts UniversityOTHER
265 Previous Clinical Trials
661,664 Total Patients Enrolled
4 Trials studying Cardiovascular Risk
1,809 Patients Enrolled for Cardiovascular Risk
Boston UniversityOTHER
454 Previous Clinical Trials
9,941,360 Total Patients Enrolled
UConn HealthLead Sponsor
211 Previous Clinical Trials
60,411 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had a heart attack, stroke, or another major heart problem.You have a job or regular activities that expose you to high levels of pollution from traffic.You have a home with a ventilation system that uses forced air pushed through vents.I am taking medication for high blood pressure or inflammation.You smoke or live with someone who smokes.You frequently use lots of candles or incense in your home.I can speak English or Spanish.I can understand and answer questions.
Research Study Groups:
This trial has the following groups:- Group 1: HEPA Filtration
- Group 2: Sham HEPA Filtration
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the cap on patient participation in this trial?
"Indeed, the listing on clinicaltrials.gov shows that this medical trial is open for enrollment as of today. Initially posted in November 2020, with its last update occurring in May 2022, it seeks to register 210 patients from a single location."
Answered by AI
Are enrollees still being accepted for this research endeavor?
"Affirmative. According to the clinicaltrials.gov database, this medical trial is currently recruiting participants which began on November 15th 2020 and was recently updated on May 11th 2022. 210 individuals are needed across 1 site for the study's completion."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger